VRNA

Verona Pharma PLC

Price

return (12m)

p/e

-113.24

p/bv

33.04

DIVIDEND YIELD

0.00%

VRNA price

Verona Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment VRNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals VRNA

Valuation

P/E

-113.24

Sector 0.84

Industry -1.42

P/BV

33.04

Sector 1.82

Industry 1.25

P/Revenue (PSR)

41.48

Sector 1.48

Industry 2.13

EV/EBITDA

473.61

Sector -43.66

Industry -35.45

EV/EBIT

481.21

Sector -47.57

Industry -38.86

P/EBITDA

-263.67

Sector -31.25

Industry -21.12

P/EBIT

-257.33

Sector -42.58

Industry -25.59

P/Total Assets

16.05

Sector 0.82

Industry 0.70

P/Net Current Assets

36.16

Sector -23.77

Industry -59.56

P/Working Capital

18.48

Sector -3.73

Industry -1.93

EPS

-0.94

Sector -0.70

Industry -1.22

BVPS

3.24

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

95.15%

Sector 49.32%

Industry 49.70%

EBITDA Margin

18.42%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-24.29%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-36.62%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.18

Sector 0.13

Industry 0.06

Profitability

ROE

-29.18%

Sector -24.30%

Industry -38.97%

ROA

-14.17%

Sector -24.50%

Industry -49.14%

ROIC

69.01%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.71

Sector 1.92

Industry 2.55

Net Debt / EBITDA

-10.29

Sector -23.10

Industry -8.80

Net Debt / EBIT

-10.46

Sector -17.84

Industry -36.75

Net Debt / Equity

-0.70

Sector -0.68

Industry -1.16

Gross Debt / Equity

0.87

Sector -0.72

Industry -0.54

Equity/Assets

0.49

Sector 0.46

Industry 0.52

Liabilities/Assets

0.51

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

40.81%

Sector -

Industry -

5Y Earnings CAGR

7.88%

Sector -

Industry -

Fundamentals VRNA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VRNA Verona Pharma PLC	$0.00	-	0.00%	-113.24	33.04	-29.18%	-36.62%
LLY Eli Lilly and Compay	$1,249.76	56.65%	0.53%	42.13	33.21	78.84%	33.53%
SNY Sanofi	$39.81	-18.25%	4.38%	3.78	0.70	18.43%	14.25%
GSK GlaxoSmithKline PLC	$49.36	16.30%	3.58%	15.38	4.34	28.24%	14.54%
CRMD CorMedix Inc.	$7.48	-26.52%	0.00%	3.04	1.23	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$25.97	9.21%	0.00%	14.41	1.47	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$13.05	-9.04%	0.64%	29.37	2.65	9.03%	10.14%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
NVS Novartis AG	$150.19	16.49%	2.05%	22.56	6.86	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$673.79	25.46%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
DHR Danaher Corporation	$224.14	8.20%	0.63%	40.42	3.08	7.61%	15.95%
HCA HCA Healthcare Inc.	$454.64	7.19%	0.66%	14.90	-31.76	-213.15%	8.77%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VRNA - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Verona Pharma

Verona Pharma PLC

Average Investor10 user rating

4.0 (3 people)

United Kingdom

21 years

Founded: 2005

2017

Time since IPO - 9 years

209

Employees

Verona Pharma PLC (United Kingdom) is listed on the Nasdaq and has a market capitalization of $9.19 billion, with shareholders equity totaling $278.27 million.

The company employs approximately 209 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Verona Pharma PLC reported $221.68 million in revenue, generating net income of $-81.19 million.

Key financial metrics include a P/E ratio of -113.24, a price-to-book (P/B) ratio of 33.04, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VRNA.

Market cap

$9.19 billion

Net worth

$278.27 million

$278,270,000.00

Assets

$572.87 million

$572,870,000.00

Total Shares Outstanding

86.00 million

86,000,000

Average Daily Trading Volume

$1.42 million

$1,422,587.96

Sector

Health

Industry

Pharmaceutical Products

VRNA

VRNA revenue and profits

Financial Results VRNA

DRAG THE FRAME TO SEE MORE DATA

VRNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76